company background image
MED logo

Medifast NYSE:MED Stock Report

Last Price

US$35.85

Market Cap

US$386.5m

7D

-4.8%

1Y

-64.6%

Updated

18 Mar, 2024

Data

Company Financials +

MED Stock Overview

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific.

MED fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Medifast, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medifast
Historical stock prices
Current Share PriceUS$35.85
52 Week HighUS$109.52
52 Week LowUS$34.09
Beta1.17
1 Month Change-28.29%
3 Month Change-46.48%
1 Year Change-64.58%
3 Year Change-84.57%
5 Year Change-72.45%
Change since IPO551.82%

Recent News & Updates

Medifast Is Getting Attractive

Mar 07

Recent updates

Medifast Is Getting Attractive

Mar 07

Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings

Feb 22
Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings

Medifast Share Price Loses Weight, But Is There Still Value To Be Had?

Jan 20

Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?

Dec 09
Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?

Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome

Nov 24

Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?

Nov 21
Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?

Medifast: Unveiling A Challenge Beyond Weight Loss Drugs

Nov 09

Medifast: The Race To Weight-Loss Drugs Not Lost Yet

Oct 09

Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs

Aug 04

Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?

Jul 26
Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?

In The Murky MLM Space, Medifast Might Actually Hold Some Promise

Jul 21

Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Jul 05
Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Medifast: In Survival Mode Against Diet Pills And The Recession

Jun 14

Medifast Holds Value During Headwinds

May 28

Medifast Non-GAAP EPS of $3.70 beats by $1.48, revenue of $337.2M beats by $7.1M

Feb 21

Medifast: A Low Earnings Multiple Despite Strong Financial Performance

Feb 07

At US$117, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?

Jan 19
At US$117, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?

Medifast declares $1.64 dividend

Dec 08

A Look At The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Dec 01
A Look At The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

Medifast's (NYSE:MED) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Nov 10
Medifast's (NYSE:MED) Sluggish Earnings Might Be Just The Beginning Of Its Problems

One Medifast, Inc. (NYSE:MED) Analyst Just Made A Major Cut To Next Year's Estimates

Nov 08
One Medifast, Inc. (NYSE:MED) Analyst Just Made A Major Cut To Next Year's Estimates

Medifast: This High-Yield Blue Chip Dividend Stock Is A Strong Buy

Nov 06

What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?

Oct 20
What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?

We Think Medifast (NYSE:MED) Can Stay On Top Of Its Debt

Sep 18
We Think Medifast (NYSE:MED) Can Stay On Top Of Its Debt

Medifast declares $1.64 dividend

Sep 08

Do Medifast's (NYSE:MED) Earnings Warrant Your Attention?

Sep 02
Do Medifast's (NYSE:MED) Earnings Warrant Your Attention?

Medifast: Let's Dive Into Its Q2 Earnings And Assess The Bad And The Good

Aug 21

Medifast, Inc. (NYSE:MED) Analysts Are Reducing Their Forecasts For This Year

Aug 09
Medifast, Inc. (NYSE:MED) Analysts Are Reducing Their Forecasts For This Year

Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?

Jul 27
Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?

What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?

Jul 12
What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?

Medifast And Its Real Value

Jun 24

Medifast: Growth And Value At A Reasonable Price

May 17

Here's Why I Think Medifast (NYSE:MED) Might Deserve Your Attention Today

May 03
Here's Why I Think Medifast (NYSE:MED) Might Deserve Your Attention Today

Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?

Apr 13
Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?

Medifast, Inc: Winning Profits In The Business Of Losing Weight

Apr 12

Medifast: A Growth Company For Value Investors

Mar 07

Shareholder Returns

MEDUS Personal ProductsUS Market
7D-4.8%-2.1%0.5%
1Y-64.6%-23.7%29.0%

Return vs Industry: MED underperformed the US Personal Products industry which returned -23.7% over the past year.

Return vs Market: MED underperformed the US Market which returned 29% over the past year.

Price Volatility

Is MED's price volatile compared to industry and market?
MED volatility
MED Average Weekly Movement8.2%
Personal Products Industry Average Movement10.0%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: MED's share price has been volatile over the past 3 months.

Volatility Over Time: MED's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980634Dan Chardhttps://medifastinc.com

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform.

Medifast, Inc. Fundamentals Summary

How do Medifast's earnings and revenue compare to its market cap?
MED fundamental statistics
Market capUS$386.52m
Earnings (TTM)US$99.42m
Revenue (TTM)US$1.07b

3.9x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MED income statement (TTM)
RevenueUS$1.07b
Cost of RevenueUS$296.20m
Gross ProfitUS$775.85m
Other ExpensesUS$676.44m
EarningsUS$99.42m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)9.22
Gross Margin72.37%
Net Profit Margin9.27%
Debt/Equity Ratio0%

How did MED perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.